See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Insulin Inhalation Prototype Demo

J. Scott MacGregor

Insulin Inhalation Prototype Demo

European Association for the Study of Diabetes

Updated 52 weeks ago
Small A1c Reduction Considerably Lessens Type 2 Death Risk
Nov 3, 2012 | 
A Swedish study has found that even less than a 1% reduction in A1c's lowered the mortality rate among type 2 patients by 50 percent compared to patients whose A1c's remained stable or increased. (Mortality was defined as the likelihood of dying from any cause within the next five years.)
High-Tech Pump Helps Three Type 1s Swim the English Channel
Dec 17, 2011 | 
On July 21, Claire Duncan was one of three people with type 1 diabetes on a six-person relay team that swam across the English Channel. The team, swimming to raise funds for the Juvenile Diabetes Research Foundation, covered the 22-mile route in 13.5 hours, starting from a beach between Folkestone and Dover in England and finishing in France near Cap Gris Nez, between Boulogne and Calais.
DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

STAT™ Medical Devices

Roger Huckleberry

STAT™ Medical Devices

Insulin Inhalation Prototype Demo

J. Scott MacGregor

Insulin Inhalation Prototype Demo

Novo Says Early Use of Victoza Aids Type 2 Control
Oct 2, 2011 | 
News from Danish pharmaceutical manufacturer Novo Nordisk reinforces the growing trend toward using a two-drug combination in the early treatment of type 2 diabetes. (See "A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes" for more discussion about this phenomenon.) In a study it released in Lisbon, Portugal, at the recent meeting of the European Association for the Study of Diabetes, Novo said that combining its recently released drug Victoza® (liraglutide) with another drug early in therapy helps recently diagnosed type 2s achieve greater blood glucose control than they can with a single drug.

Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54